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Introduction: Stroke rehabilitation should start early in order to optimize patients’
outcomes, but most trials include subacute or chronic patients. Although suggested
that early stroke rehabilitation trials face difficulties regarding patient recruitment with
corresponding low recruitment rates, no systematically collected information regarding
screening and associated costs has been published. Such knowledge is essential
for optimizing enrollment. Therefore, this study evaluated screening procedures for an
early upper limb rehabilitation study including first-ever ischemic stroke patients <48 h
after onset.
Methods: Screening data for a monocentric longitudinal observational cohort study
was prospectively collected. Researchers screened health-care records, during the
morning round and face-to-face at the stroke-unit on working days. Outcomes were
the recruitment rate, reasons for non-enrollment, and screening costs.
Results: Over 15 months, 27 out of 845 screened ischemic stroke patients were
enrolled, equaling a recruitment rate of 1.8/month. Main reasons for non-enrollment were
no upper limb paresis (N = 456), >48 h post-stroke (N = 257), general comorbidity (N
= 150), unable to follow commands (N = 148), and recurrent stroke (N = 146). Four
patients were missed due to time constraints of the personnel or patient. The recruitment
rate would have been 1.2 higher if also patients with recurrent strokes but without residual
motor deficits or pre-stroke mRS ≥2 were considered eligible. Screening costed e 7.48
per patient.
Discussion: Screening at working days is sufficient to enroll patients in early stroke
rehabilitation trials. Inclusion criteria regarding recurrent strokes should be less stringent
to boost recruitment rates without increasing bias. Multicenter collaborations are needed
to finish well-powered early stroke rehabilitation studies within a reasonable time.
Ethics and Study Registration: Authorization from the local ethical committee was not
required, as this study does not fall within the scope of the Human Research Act (BASEC
Identifier: Req-2017-00844). The project was registered at http://www.clinicaltrials.gov
(Identifier: NCT03633422).
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INTRODUCTION
It is assumed that rehabilitation should be initiated early after
stroke in order to optimize stroke outcomes (1). However,
stroke rehabilitation studies have traditionally been performed in
patients beyond the first 4–12 weeks post-stroke (2). Therefore,
it has been stressed that future stroke rehabilitation trials should
include patients early after symptom onset (2).
The change toward “acute” stroke rehabilitation trials has
major consequences for clinical trial design and particularly for
participant screening procedures. However, little information is
available regarding screening procedures for these early initiated
trials, including recruitment rates, exclusion reasons, and costs.
It is likely that recruitment rates will be low, as diagnostic
procedures and medical interventions are first priority early
after stroke. A recent review by Feldman et al. (3) supports
the expected difficulties for patient recruitment in very early
stroke rehabilitation trials. They showed that the development
of recruitment rates for acute medical stroke trials has been
sobering during the last 20 years: from 1990 to 2004, 0.41
participants were enrolled per site per month and between 2010
and 2014, this number has decreased to 0.26. Researchers of
the largest randomized controlled trial in stroke rehabilitation,
the A Very Early Rehabilitation Trial (AVERT), had to screen
25,237 patients at 56 stroke units in five countries over an 8
year time course to enroll 2’104 patients (4) and this underlines
the difficulties to recruit patients early after stroke. The trial
flow provides some information regarding the exclusion reasons,
but not in detail and for about one quarter of the non-
eligible patients, the reason remained unclear. The monocentric
observational SALGOT-study had better recruitment rates—
over 18 months, 117 out of 763 screened first-ever stroke
patients were enrolled <72 h post-stroke (5) and the researchers
provided more details regarding the selection process. However,
the applied screening procedures and their associated costs
remained unclear.
Knowledge regarding screening procedures for early
stroke rehabilitation trials is essential for optimizing the
design and completion of stroke rehabilitation trials (6) and
with that, timely answering questions regarding post-stroke
recovery and the efficacy of early rehabilitation interventions.
Therefore, our main aim was to describe the recruitment
rate for an early longitudinal observational upper limb
rehabilitation study post-stroke (i.e., <48 h), including a detailed
analysis of exclusion reasons. The secondary aims were to
gain insight in time investment and costs associated with
eligibility screening.
METHODS
Definition
In the present work, the following definition was applied for
screened patients: “Screened patients could broadly be defined
as patients with the disease who present at the site(s) during the
recruitment time interval, including those who were not formally
assessed for eligibility” (7).
Study Design
The screening procedures for a monocentric, prospective
observational cohort study were evaluated (ClinicalTrials.gov
identifier NCT03633422). The main goal of the cohort study was
to externally validate the Shoulder Abduction Finger Extension
(SAFE) model (8) within 48 h after stroke for predicting outcome
of upper limb capacity 3months after symptom onset. The study’s
inclusion criteria were (1) a first-ever unilateral ischemic stroke
<48 h confirmed by diffusion-weighted magnetic resonance
imaging and/or computed tomography; (2) age ≥18 years; (3)
able to follow one-staged commands; (4) National Institutes of
Health Stroke Scale (NIHSS) arm score of ≥1; and (5) informed
consent. Main exclusion criteria were (1) pre-stroke modified
Rankin Scale score of >2; (2) neurological or other diseases
affecting the upper limb(s) before stroke; (3) intravenous line in
the upper limb(s) limiting assessment; (4) contra-indications on
ethical grounds (such as palliative stroke care, imprisonment);
and (5) expected or known non-compliance (such as alcohol and
drug abuse).
The estimated number of patients to be enrolled in 1 year
was 40, equaling a monthly recruitment rate of 3.3. Recruitment
started on the 01/10/2017 at the University Hospital Zurich,
Department of Neurology, Zurich, Switzerland. The acute stroke
unit has eight beds and a yearly admission rate of about 800 acute
stroke patients in the period 2010–2016. For the present work,
data obtained until 31/12/2018 were considered.
For evaluating screening procedures, authorization from
the local ethical committee was not required, as this does
not fall within the scope of the Swiss Human Research Act
(BASEC identifier Req-2017-00844). The prospective cohort
study on which we applied the evaluation of screening
procedures was approved by the cantonal ethics committee
Zurich (BASEC identifier Req-2017-00889; ClinicalTrials.gov
identifier NCT03287739).
Screening Procedures and Outcomes
Screening was performed by one of the researchers fromMonday
to Friday during the morning round, twice a day in electronic
files, and if indicated, face-to-face on the ward. Screening on
the ward was performed when the stroke patient was, based on
descriptive reports, likely to be eligible. The following data was
prospectively collected: number of patients screened; reasons for
non-enrollment; number of enrolled patients; gender; NIHSS at
screening; the application of thrombolysis and thrombectomy;
time needed for each patient identification method (5min
blocks); and number of patients screened on the ward. Main
outcomes were the recruitment rate, defined as the number of
patients enrolled per month of recruitment (9), and frequency of
each of the exclusion reasons. Secondary outcomes were the time
investment associated with screening expressed as minutes per
day and corresponding personnel costs in Euros.
Analysis
Recruitment rate and reasons for exclusion were analyzed by
descriptive statistics. Time needed for screening was calculated
by summing the minutes spent on each identification method
divided by the number of screening days. Costs associated with
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screening one patient was calculated as follows:
Costs =
(Total screening time
[
hours
]
∗€ 49.37)
Number of screened patients
We furthermore calculated the screening costs associated with
enrolling one patient:
Costs =
(Total screening time
[
hours
]
∗€ 49.37)
Number of enrolled patients
Analyses were performed with IBM SPSS Software version 25
(IBM Analytics).
RESULTS
Eight hundred forty-five patients were screened in 15months, out
of which 110 were screened on the ward (see Table 1). During
screening on the ward, the following criteria had to be checked
for: NIHSS arm score, the ability to follow one-staged commands
and the presence of intravenous lines hampering assessment.
Patient characteristics can be found in Table 2. Two patients
fulfilled all eligibility criteria, except for consent to participate.
Thirty-one patients were eligible out of which three could not
be enrolled due to time constraints of the study personnel and
one due to a full patient schedule. Thus, the actual recruitment
rate amounted 1.8 per month, but would have been 2.1 if
the four patients fulfilling the criteria but were not enrolled
had participated.
Non-eligible patients had a median of two (interquartile
range 1–3) exclusion reasons. The main exclusion reasons were
an NIHSS arm score of zero at screening (N = 456, 54%),
>48 h post-stroke (N = 257; 30.4%), general comorbidity (N
= 150; 17.8%), unable to follow one-staged commands (N
= 148; 17.5%), and a recurrent stroke (N = 146; 17.3%).
Please see Figure 1 for an overview of all exclusion reasons
and Figure 2 for a cumulative presentation of the exclusion
reasons. To provide more insight in the exclusion reasons,
we subdivided “(1) a first-ever unilateral ischemic stroke
<48 h confirmed by diffusion-weighted magnetic resonance
imaging and/or computed tomography” into stroke localization
(bihemispheric) and recurrent strokes, and “comorbidity” into
TABLE 1 | Screening characteristics.
Patients screened
Ischemic stroke patients screened in total, N 845
Ischemic stroke patients screened on ward, N 110
Eligible ischemic stroke patients, N (%) 31 (3.8%)
Included, N (%) 27 (3.2%)
Not included due to time constraints researchers, N 3
Not included due to time constraints patient, N 1
Patients screened >48 h, N 257
Due to absence researchers, N (%) 181 (70.4%)
Fulfilled all other criteria, N (%) 0 (0.0%)
Due to late admission, N (%) 76 (29.6%)
general comorbidity (e.g., Morbus Parkinson), and specific
upper limb comorbidity (e.g., arthrosis of the hand or humerus
fracture). Patients not residing in Switzerland could not be
included, as they would not be available for the follow-up visit
at 3 months post-stroke, the main outcome time point of the
longitudinal cohort study.
Ninety-seven (21.3%) of the patients with an NIHSS arm
score of zero at screening had an NIHSS arm score of one or
more points at hospital admission. Reasons for screening patients
>48 h post-stroke was due to absence of study personnel in
70.4% and late admission in 29.6% of the cases. Absence of study
personnel referred to weekends, (public) holidays and conference
attendance. None of these late-screened patients fulfilled the
other study criteria.
Post-hoc analysis showed that 18 patients with a recurrent
stroke did not have any other exclusion reason and 13 of them
had no residual motor deficits. Removing themRS as an inclusion
criterion for our upper limb rehabilitation study would have led
to five more patients being eligible.
Daily screening time amounted 9.15min for electronic
records, 14.24min for morning rounds, and 4.55min on the
ward (Table 3). Screening one patient took on average 9.09min,
which costed e 7.48. To enroll one patient, 264.83min had to be
screened, costing e 217.91.
DISCUSSION
Prospectively observing eligibility screening procedures for an
early upper limb motor rehabilitation study showed that about
two stroke patients a month could be enrolled in our center,
although the target was 3.3. An NIHSS arm score of zero was by
far the most frequently observed exclusion reason, followed by
TABLE 2 | Patient characteristics.
Gender, female/male* 366 (43.3%)/479 (56.7%)
Thrombolysis, yes/no* 223 (26.4%)/611 (72.3%)
Thrombectomy, yes/no* 215 (25.4%)/619 (73.3%)
Length of hospital stay, days† 8 (4–12)
NIHSS
Total admission† 5 (2–12)
Arm admission† 1 (0–3)
Arm admission ≥1, yes/no* 459 (54.3%)/385 (45.6%)
Arm screening ≥1, yes/no* 388 (45.9%)/456 (54.0%)
Recovered NIHSS arm from admission to screening*‡ 97 (21.1%)
Thrombolysis, yes/no* 44 (45.4%), 50 (51.5%)
Thrombectomy, yes/no* 23 (23.7%), 71 (73.2%)
Not recovered NIHSS arm from admission to
screening*§
362 (78.9%)
Thrombolysis, yes/no* 108 (29.8%)/250 (69.1%)
Thrombectomy, yes/no* 143 (39.5%)/215 (59.4%)
NIHSS, National Institutes of Health Stroke Scale; *, N (%); †, median (interquartile
range); ‡, NIHSS arm ≥1 at admission to 0 at screening; §, NIHSS arm ≥1 at admission
and at screening. Percentages not counting up to 100 reflect the percentage of
missing data.
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FIGURE 1 | Overview of exclusion reasons for non-eligible patients (N = 814). Exclusion reasons arranged in descending order based on their prevalence. Stroke
localization (bihemispheric) and recurrent stroke refer to the inclusion criterion “first-ever unilateral ischemic stroke.” The criterion “comorbidity” was divided into
general comorbidity (e.g., Morbus Parkinson) and specific upper limb comorbidity (e.g., arthrosis of the hand, humerus fracture). Patients not residing in Switzerland
could not be enrolled, as they would not be able to return for the follow-up visits. Four patients fulfilling the criteria could not be enrolled due to time constraints of
researchers (N = 3) or patient (N = 1). h, hours; NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin Scale; *One data point missing.
FIGURE 2 | Overview of cumulative exclusion reasons. Light-green bars indicate the number of patients fulfilling all previous criteria but not the current criterion.
Dark-green bars indicate number of patients fulfilling all previous criteria including the current criterion. Exclusion reasons arranged in ascending order based on their
prevalence. Stroke localization (bihemispheric) and recurrent stroke refer to the inclusion criterion “first-ever unilateral ischemic stroke.” The criterion “comorbidity” was
divided into general comorbidity (e.g., Morbus Parkinson) and specific upper limb comorbidity (e.g., arthrosis of the hand, humerus fracture). Patients not residing in
Switzerland could not be enrolled, as they would not be able to return for the follow-up visits. h, hours; NIHSS, National Institutes of Health Stroke Scale; mRS,
modified Rankin Scale; *One data point missing.
screening >48 h post-stroke, the presence of interfering general
comorbidities, unable to follow commands, and a recurrent
stroke. The applied screening procedures took about 9min per
patient and costed e 7.48. The screening costs per enrolled
patient amounted e 217.91, excluding the consent process.
With 1.8 per month, the enrolment rate in our center is
higher than the recruitment rates per center of early multicenter
rehabilitation trials like the randomized controlled AVERT-study
(0.38) (4) and observational EPOS-study (0.74) (8), but lower
than the observational monocentric SALGOT-study (6.5) (5). A
relatively high enrollment rate in monocentric studies could be
attributed by the full-time presence of dedicated, experienced
research personnel as a driving force behind patient inclusion
and alternative consent procedures (10). However, it is not
surprising that the total number of enrolled patients per month
for monocentric studies was lower than for multicentric studies.
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TABLE 3 | Time investment and costs related to screening.
Total number of screening days, N 275
Total screening time, minutes/day 27.93
Electronic health-care records, minutes/day 9.15
Morning rounds, minutes/day 14.24
Ward, minutes/day 4.55
Minutes screened/patient 9.09
Minutes screened/enrolled patient 264.83
Costs per screened patient, e 7.48
Costs per enrolled patient, e 217.91
Considering our recruitment rate and that a high number of
patients are needed for well-powered upper limb randomized
trials (11), multiple centers should be involved to complete
the study within an acceptable timeframe. Furthermore, our
recruitment rate could have been 0.9 per month higher if also
patients with recurrent strokes without residual motor deficits
were deemed eligible (i.e., 13 more patients would have been
eligible). Another possibility to increase the recruitment rate for
upper limb trials is by deciding against taking a pre-stroke mRS
score as an inclusion criterion, as long as global disability is not
the main outcome. A higher mRS score does not necessarily
reflect limitations in upper limb function prior to stroke. In our
case, this would have led to five more patients being eligible, i.e.,
the recruitment rate would have been 0.3 higher. In addition,
including hemorrhagic stroke patients, like done in the SALGOT-
study (5), could have improved the recruitment rate. Strategies to
increase enrollment rates for studies with chronic stroke patients,
such as referral through health-care provides, advertisement,
or postal invitations (12–15) are unfortunately not transferable
to acute studies. We expected that early recruitment would be
hampered by early medical diagnostics and interventions, but
only one patient could not be included due to a full schedule,
mainly related to a diagnostic work-up.
The lack of an upper limb paresis was themain reason for non-
enrollment; 54.3% of the patients had an NIHSS arm score of ≥1
at hospital admission and 21.3% of them had a fully recovered
arm at screening. The recent SALGOT-study reported a similar
prevalence within 72 h post-stroke (16). This is interesting, as a
few decades ago, prevalence estimates of upper limb paresis up
till 80% were reported (17). Acknowledging that most prevalence
data are obtained before the implementation of thrombolysis and
endovascular treatment (18), it could be hypothesized that the
availability of effective early medical interventions might have
led to the fast recovery of arm paresis early after symptom onset
and as a consequence a reduced number of eligible patients. The
difference could also be a result from how we objectified upper
paresis. The NIHSS assesses strength of the proximal upper limb
on a 5-point scale, ranging from “0” (normal strength) to “4” (no
movement). However, a maximal score of zero does not mean
that there could not be a strength deficit in the more distal part of
the arm. In addition, muscle contraction against resistance is not
tested. Therefore, the Motricity Index (19) or the SAFE-score (8)
are better screening tools, as they allow quickly measuring both
the proximal and distal upper limb and do consider resistance.
The Action Research Arm Test or Fugl-Meyer Assessment are
even more likely to show motor limitations (16), but also require
much more time.
With 30.4% of the patients screened beyond 48 h after onset,
the present study also showed that including patients early post-
stroke is challenging. Twenty-nine point six percent of these
patients were admitted >48 h, the other 70.4% was screened
too late due to absence of study personnel. Fortunately, none
of the latter fulfilled the other inclusion criteria, although
this could be the case, as patients admitted between Friday
afternoon and Saturday morning are outside the 48 h timeframe
on Monday morning. This implies that eligibility screening for
early rehabilitation trials does not necessarily require availability
of research personnel in the weekend, unless the period for
inclusion is restricted to the first 24 to 36 h post-stroke.
The main limitation of this work is that it refers to
a monocentric study, which might hamper generalizing
its findings.
SUMMARY/CONCLUSIONS
Our work highlighted the efforts needed to screen patients
for early stroke rehabilitation trials and the associated costs.
Screening on working days by dedicated research personnel
should be sufficient as long as patients can be enrolled up to
at least 48 h after symptom onset. However, multiple centers
are required to finish well-powered early stroke rehabilitation
trials with an acceptable timeframe. For upper limb trials,
screening by the NIHSS arm item might be too global
and results in non-enrollment of patients who have a more
distal paresis. Furthermore, the inclusion of patients with a
recurrent stroke should be considered, as long as they have
no residual deficits, or those with a pre-stroke mRS of >2
but without comorbidities affecting the upper limb, as well as
hemorrhagic strokes. Therewith, both recruitment rates and
generalizability could be improved, and study duration and
corresponding costs decreased. Finally, we advocate that future
trialists describe their reasons for non-enrollment into more
detail, as this helps the readers critically judge the transfer
of the results as well as other early stroke rehabilitation
trialists in designing their inclusion and exclusion criteria
more carefully.
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